Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CollPlant Biotechnologies Q2 Adjusted EPS $0.52 Beats $0.01 Estimate, Sales $10.18M Beat $5.15M Estimate

Author: Benzinga Newsdesk | August 24, 2023 07:05am
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.01 by 5100 percent. This is a 244.44 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $10.18 million which beat the analyst consensus estimate of $5.15 million by 97.75 percent. This is a 15.33K percent increase over sales of $66.00 thousand the same period last year.

Posted In: CLGN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist